Enzolytics Inc. (OTCMKTS: ENZC) Advancing its ITC-1 Anti-HIV Therapy to Clinical Trials under EMA Across Europe
Enzolytics Inc. (OTCMKTS: ENZC) has finalized plans to advance the previously tested ITV-1 anti-HIV treatment to clinical studies and supply across Europe. Completing the steps will establish the anti-HIV therapy as a potential revenue source, a significant milestone for Enzolytics’ profitability and human health. Anti-HIV therapy progressing to clinical studies under EMA The anti-HIV therapy had progressed toward Bulgarian Drug Agency certification, but the process was halted before completion. But,…